Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020

SELL
$64.27 - $86.37 $7.49 Million - $10.1 Million
-116,564 Closed
0 $0
Q3 2019

Nov 05, 2019

SELL
$67.4 - $85.11 $14.4 Million - $18.2 Million
-213,665 Reduced 64.7%
116,564 $7.86 Million
Q2 2019

Aug 14, 2019

SELL
$80.35 - $93.9 $66.7 Million - $78 Million
-830,717 Reduced 71.56%
330,229 $28.3 Million
Q1 2019

May 13, 2019

BUY
$84.2 - $98.62 $4.76 Million - $5.57 Million
56,500 Added 5.12%
1,160,946 $103 Million
Q4 2018

Feb 08, 2019

BUY
$80.14 - $106.07 $8.53 Million - $11.3 Million
106,391 Added 10.66%
1,104,446 $94 Million
Q3 2018

Oct 25, 2018

BUY
$93.92 - $105.72 $2.8 Million - $3.16 Million
29,852 Added 3.08%
998,055 $96.8 Million
Q2 2018

Jul 30, 2018

BUY
$76.01 - $99.03 $629,514 - $820,166
8,282 Added 0.86%
968,203 $91.2 Million
Q1 2018

May 04, 2018

BUY
$77.67 - $92.63 $1.18 Million - $1.41 Million
15,213 Added 1.61%
959,921 $77.8 Million
Q4 2017

Feb 14, 2018

BUY
$80.76 - $95.13 $2.29 Million - $2.7 Million
28,383 Added 3.1%
944,708 $84.2 Million
Q3 2017

Nov 14, 2017

SELL
$80.6 - $94.95 $2.32 Million - $2.73 Million
-28,756 Reduced 3.04%
916,325 $85.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
945,081
945,081 $85.8 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15.6B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.